Table 4:

Rates of Favorable and Excellent Outcome at 1 Year after after S3-TAVR, XT-TAVR, and SAVR

	S3-TAVR vs. SAVR			S3-TAVR vs. XT-TAVR
	S3-TAVR (N = 972)	SAVR (N = 713)	P-Value	S3-TAVR (N = 972)	XT-TAVR N = 835)	P-Value
Favorable Outcome *	75.5%	70.0%	0.018	75.5%	68.3%	0.001
Excellent Outcome †	59.6%	53.2%	0.008	59.6%	54.7%	0.058

^*Defined as combination of survival and KCCQ-OS score > 60 in the absence of a decline in KCCQ-OS score of ≥ 10 pts from baseline

^†Defined as combination of survival and KCCQ-OS score > 75 in the absence of a decline in KCCQ-OS score of ≥ 10 pts from baseline

Abbreviations: KCCQ – Kansas City Cardiomyopathy Questionnaire